Skip to main navigation Skip to search Skip to main content

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients

    Project: Research

    Project Details

    StatusActive
    Effective start/end date10/1/13 → …